Ronald M Krauss

This inventor holds 18 USPTO granted patents and 6 published patent applications, plus 4 CIPO patents and 4 EPO patents. Top assignees: Quest Diagnostics Investments, Inc., University of California, Children's Hospital Research Center at Oakland. Active years: 1986-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ronald M Krauss. Retrieved from https://idiyas.com/inventor/ronald-m-krauss

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 18 (Patent Applications = 6)

% Patents Active = 83.3

CIPO Patents = 4

EPO Patents = 4 (Patent Applications = 4)

Average Co-Inventor Count = 3.8

ph-index = 4

Forward Citations = 95(Granted Patents)

Company Filing History:

7 out of 499

Quest Diagnostics Investments, Inc.

patents

6 out of 16,008

University of California

patents

3 out of 77

Children's Hospital Research Center at Oakland

patents

4. 1 out of 25

Children's Hospital & Research Center Oakland

patents

5. 1 out of 43

Cymabay Therapeutics, Inc.

Lipomics Technologies, Inc.

patents

8. 1 out of 1,808

Mayo Foundation for Medical Education and Research

patents

where one patent can have more than one assignee

Years Active: 1986-2024

Loading Chart...

18 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12055554 - Lipoprotein analysis by differential charged-particle mobility (2024-08-06),

2. 11680949 - Lipoprotein analysis by differential charged-particle mobility (2023-06-20),

3. 11007162 - Methods of reducing small, dense LDL particles (2021-05-18),

4. 10948503 - Lipoprotein analysis by differential charged-particle mobility (2021-03-16),

5. 9857385 - Ultra-small apoB-containing particles and methods of use thereof (2018-01-02),

6. 9791464 - Lipoprotein analysis by differential charged-particle mobility (2017-10-17),

7. 9322833 - Ultra-small ApoB-containing particles and methods of use thereof (2016-04-26),

8. 9046539 - Lipoprotein analysis by differential charged-particle mobility (2015-06-02),

9. 8709818 - Lipoprotein analysis by differential charged-particle mobility (2014-04-29),

10. 8247235 - Lipoprotein analysis by differential charged-particle mobility (2012-08-21),

11. 8137977 - Lipidomic approaches to determining drug response phenotypes in cardiovascular disease (2012-03-20),

12. 8097462 - Aerosol preparation of intact lipoproteins (2012-01-17),

13. 8084209 - HMGCR isoforms in prediction of efficacy and identification of cholesterol-modulating compounds (2011-12-27),

14. 7851224 - Method of assessing a lipid-related health risk based on ion mobility analysis of lipoproteins (2010-12-14),

15. 7713744 - Determining the risk of cardiovascular disease using ion mobility of lipoproteins (2010-05-11),

Title: Innovator Spotlight: Ronald M Krauss - A Pioneer in Lipoprotein Analysis

Introduction:

Ronald M Krauss, a distinguished inventor based in Berkeley, CA, has made significant contributions to the field of lipoprotein analysis. With an impressive portfolio of 18 patents, Krauss continues to revolutionize diagnostic methods for assessing lipid-related health risks and cardiovascular conditions.

Latest Patents:

Krauss's latest patents focus on lipoprotein analysis by differential charged-particle mobility. These inventions offer advanced methods for preparing and analyzing lipoproteins, including HDL, LDL, Lp(a), IDL, and VLDL, from biological samples. The innovative differential charged particle mobility analysis techniques provide crucial insights into lipoprotein size distributions, enabling accurate assessments of cardiovascular risks and the effectiveness of therapeutic interventions.

Career Highlights:

Throughout his career, Ronald M Krauss has been associated with prestigious institutions such as Quest Diagnostics Investments, Inc. and the University of California. His groundbreaking research and inventions have not only advanced the field of lipoprotein analysis but have also paved the way for enhanced diagnostic tools in personalized medicine and cardiovascular health.

Collaborations:

Krauss has collaborated with esteemed colleagues, including Patricia J Blanche and W Henry Benner, in his research endeavors. Together, they have worked towards improving the accuracy and efficiency of lipoprotein analysis, contributing to the development of cutting-edge diagnostic solutions.

Conclusion:

In conclusion, Ronald M Krauss's innovative work in lipoprotein analysis has significantly impacted the healthcare industry, offering valuable insights into lipid-related health risks and cardiovascular conditions. His dedication to advancing diagnostic methods underscores his commitment to improving patient outcomes and driving innovation in personalized medicine.

Profile summary based on public USPTO records.